Vox Sanguinis

Article	Citations
	29
Cord blood freezing bag breakage at transplant centres: Low breakage rate in Japan	26
Events	21
Basophil activation test for allergic and febrile non‐haemolytic transfusion reactions among paediatric patients with haematological or oncological disease	20
Issue Information	19
Issue Information	19
Anti‐monkeypox virus‐neutralizing activities of human immunoglobulin manufactured between 1999 and 2021 and derived from donors in the United States and Japan	17
A positive blood culture is associated with a lower haemoglobin increment in hospitalized patients after red blood cell transfusion	17
Issue Information	16
A novel syphilis Treponema pallidum lipoprotein peptide antigen diagnostic assay using red cell kodecytes in routine blood centre column agglutination testing platforms	16
Supplying whole blood with drones for prehospital transfusion at trauma sites in Finland: A simulation	15
Anti‐D prophylaxis should protect all newborns from haemolytic disease, regardless of their country of residence	14
Risk of a blood donation contaminated with hepatitis E virus entering the blood supply before the implementation of universal RNA screening in France	14
The efficacy of interactive communication interventions for motivating blood donation: A systematic review	14
Removing hepatitis C antibody testing for Australian blood donations: A cost‐effectiveness analysis	14
Bacterial proliferation is comparable in red blood cell concentrates stored in DEHT / PAGGSM and	13
Quality assessment and harmonization of laboratories across Europe for multiple SARS‐CoV‐2 serology assays	13
The prototypical UK blood donor, homophily and blood donation: Blood donors are like you, not me	12
Investigating human platelet antigens and antibodies in pregnancy: An 11‐year experience from a Canadian reference laboratory	12
ISBT Working Party on Information Technology Guideline on external electronic communication of transfusion traceability information	12
Transfusion‐associated acute lung injury following albumin treatment in liver disease	11
Integrated serological and molecular investigation of ABO subgroups underlying atypical ABO typing	11
Evaluation of bleed duration and adverse donor reactions during the blood donation process	11
West Nile and Usutu viruses are efficiently inactivated in platelet concentrates by UVC light using the THERAFLEX UV‐Platelets system	11
Examining prosocial tendencies in men who have sex with men: Potential impacts on blood donation following the 2023 reform	11

Issue Information	10
	10
Events	10
	10
Non‐neutralizing antibody profiles against hepatitis B virus: A comparative study of Japanese‐ and US‐donor‐derived intramuscular human hepatitis B‐specific immunoglobulin preparations	10
RhD mismatch does not affect haematopoietic recovery, graft‐versus‐host disease and survival in allogeneic haematopoietic cell transplantation: A Japanese registry‐based study	10
Evidence that CD36 is expressed on red blood cells and constitutes a novel blood group system of clinical importance	10
Events	9
Development of an in‐house bone marrow collection kit: The Catalan bone marrow transplantation group experience	9
Parents' perception and knowledge regarding blood transfusion in a tertiary care paediatric centre in India	9
Research partnerships between blood services and public health authorities: An international, cross‐sectional survey	9
Harnessing big data and artificial intelligence in transfusion medicine: Opportunities for precision, safety and efficiency	9
Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low‐ and middle‐income countries	9
Impact of conflict/war disasters on blood banks and transfusion services in low‐ and middle‐income countries in the Eastern Mediterranean region	9
Plasma transfusion practices: A multicentre electronic audit	9
Virtual platelet cross‐matching as transfusion management for patients with immune platelet refractoriness	9
Issue Information	9
Events	9
	9
Real‐world performance of a clinical droplet digital polymerase chain reaction assay for non‐invasive foetal blood group and platelet antigen genotyping of alloimmunized pregnant women with antibodies	9
Demographics and donor motivation drive declining blood donations: A 15‐year study in Germany reflecting trends in high‐income countries	8
Re‐evaluating treatment thresholds in patient blood management: Female patients experience more perioperative anaemia and higher transfusion rates in major elective surgery	8
Has the switch to sexual risk behaviour screening impacted deferrals for pre‐ and post‐exposure prophylaxis therapy for human immunodeficiency virus?	8
Blood transfusion dynamics in Colombia: Unveiling patterns, reactions and survival rates in multitransfused patients	8
Notification of blood donors who test positive for transfusion‐transmissible infections	8
Events	8
Proof of concept for detection of staphylococcal enterotoxins in platelet concentrates as a novel safety mitigation strategy	8
Issue Information	8
In vitro quality assessment of red blood cells and plasma units in DEHT / SAGM bags and	8
Deferral of blood donors who have ever stayed in a Trypanosoma cruzi endemic area: An international survey	8
Successful implementation of a patient blood management programme in a lower middle‐income state	8
The role of CD36 antibodies in haematopoietic stem cell transplantation	8
Voluntary blood donation preferences in China: A discrete choice experiment among experienced and inexperienced donors	8
Evaluation of immunoglobulin replacement therapy in secondary immunodeficiency at three British Columbia hospitals	8
Pre‐donation deferral rates and causes among whole blood and apheresis platelet donors in China: A multi‐centre retrospective study (2016–2024)	8
	8
End of selection criteria based on sexual orientation: An international symposium on alternatives to donation deferral	7
Securing commitment and control for the supply of plasma derivatives for public health systems. I: A short review of the global landscape	7
A norm for all seasons: Application of the ISO 14001 standard to manage the environmental impacts of transfusion	7
International Forum on Genotyping of Blood Antigens in Donors: Summary	7
Is it time for the death knell of single‐unit plasma?	7
Use of O RhD‐negative red blood cells: A nationwide, prospective audit	7
Fundamentals of big data and artificial intelligence in transfusion medicine	7
Issue Information	7
Transforming transfusion safety: Insights from implementing bedside electronic checks at a large UK National Health Service trust	7
International Forum on Transfusion Education for Healthcare Professionals Who Administer Blood to Patients in Hospitals and Health Services: Summary	7
Identification of a novel variant c.761C>T onABO*B.01gene in ABO glycosyltransferases associated with Bweakphenotype	7
Alemtuzumab and autoimmune haemolytic anaemia: Coincidence or causation?	7
Analysis of maternal Fc gamma receptor IIIb isoantibodies using immunomagnetic negative selected neutrophils	7
Laboratory approach for vaccine‐induced thrombotic thrombocytopenia diagnosis in the Netherlands	7

Ethnic diversity in Chilean blood groups: A comprehensive analysis of genotypes, phenotypes, alleles and the immunogenic potential of antigens in northern, southern and central regions	7
Author Index	7
Iron recovery dynamics after whole blood donation and the effect of low‐dose iron supplementation in Japanese donors	7
Characterization of transfusion‐relevant bacteria reference strains in a lyophilized format	7
Evaluation of a method to fluorescently label platelets for in‐human recovery and survival studies	7
Molecular biology analysis of ABO blood group variants caused by natural chimaerism	7
Identification of breakpoint regions and single nucleotide variations of RHD hybrid alleles by long‐read sequencing	7
Dengue, chikungunya and Zika virus surveillance in blood donors in Brazil , 2019–2021	7
Events	7
Meteorological elements associated with vasovagal reactions in blood donors: Influence of collection setting and donation type	6
The association between attitude towards facemasks, quality of donation experience and relationship with healthcare providers: A cross‐sectional exploratory study	6
Standardized electronic messages to enhance communication in transfusion and transplantation	6
Beyond transfusion: Platelet‐derived therapeutic products as a new frontier for blood establishments and transfusion medicine	6
Current practices for recruitment and retention of plasma donors across 17 countries: A short report	6
Multinational transfusion practices and outcomes in haematology patients admitted to the intensive care unit	6
Screening, genotyping and haematological analysis of glucose‐6‐phosphate dehydrogenase deficiency in the blood donors of Wuxi City, China	6
Blood donor safety and selection criteria for individuals self‐identifying as trans or non‐binary	6
Evaluation of cell collection efficiency in non‐mobilized adult donors for autologous chimeric antigen receptor T‐cell manufacturing	6
Coagulation assay results at birth in preterm infants: A cohort study highlighting the relevance of local reference values for interpretation	6
Closed system production of serum eye drops using dockable saline	6
Advancing resilience and sustainability in plasma collections and plasma‐derived medicinal product accessibility	6
Tetanus antibodies in normal human immunoglobulin preparations	6
In vitro comparison of cold‐stored whole blood and reconstituted whole blood	6
Events	6
Assessment of amino acids and metabolites in the supernatant of stored concentrates blood from sickle cell trait (SCT) and reference (non‐SCT) donors	6
Characteristics of red blood cell transfusion among very preterm infants in China	6
Comment on ‘Frederic Duran‐Jordà: 120th anniversary of the birth of a transfusion pioneer’	6
Age, CD34+ cell dose, conditioning and pre‐transplant cytopenias can help predict transfusion support in lymphoma patients undergoing autologous stem cell transplantation	6
Issue Information	6
	6
Incidence and determinants of red cell alloimmunization and autoimmunization in paediatric thalassaemia: A North Indian cohort study	6
Events	6
Evaluating alloimmunization risk in patients with sickle cell disease and in prenatal care patients with RHCE	6
Pathogen reduction with methylene blue does not have an impact on the clinical effectiveness of COVID‐19 convalescent plasma	6
Efficacy of intravenous immunoglobulin following plasma exchange in the management of ABO haemolytic disease of the newborn	6
The contemporary management of haemolytic disease of the fetus and newborn	6
Human immunodeficiency virus, hepatitis C virus and hepatitis B virus incidence in blood donors from 2000 to 2020 in France: Trends and lessons from haemovigilance surveillance	6
Can volume‐reduced plasma products prevent transfusion‐associated circulatory overload in a two‐hit animal model?	6
	5
Does high body mass index (>25 kg/m2) or weight (>80 kg) reduce the effectiveness of anti‐D prophylaxis in Rh(D)‐negative pregnant women? A systematic review and meta‐analysis	5
Irregular antibodies in paediatric haematological disorders: Prevalence and characteristics from a Vietnamese tertiary centre	5
Response of the Japanese Red Cross Blood Center in Ishikawa Prefecture to the 2024 Noto Peninsula earthquake	5
Analysis of gender representation on transfusion medicine journal editorial boards: Comparison between 2019 and 2022	5
Enhanced O 2 availability in platelet concentrates stored for neonatal t	5
Author Index	5
Issue Information	5
	5
Risk of variant Creutzfeldt–Jakob disease in a simulated cohort of Canadian blood donors	5
Diary of Events	5
Frequency of human platelet antigens (HPA) in the Greek population as deduced from the first registry of HPA‐typed blood donors	5
Use of preoperative erythropoietin‐stimulating agents is associated with decreased thrombotic adverse events compared to red blood cell transfusion in surgical patients with anaemia	5
Meta‐analysis of efficacy and safety of pathogen‐reduced platelet components: Request for clarification	5
Events	5
	5
Events	5
Determination of IgG1 and IgG3 subclasses of red blood cell antibodies: An important tool for pred	5
Current state of gene therapy in sickle cell disease	5
	5
International Society for Blood Transfusion Guidelines for Validation of Automated Systems in Blood Establishments	5
Hepatitis B virus genotype surveillance in Canadian blood donors and a referred patient population, 2016–2021	5
Therapeutic efficacy and safety of pathogen‐reduced platelet components: Results of a meta‐analysis of randomized controlled trials	4
Issue Information	4
Diary of Events	4
Issue Information	4
The evolution and interpretation of seroprevalence of SARS‐CoV‐2 antibodies among South African blood donors from the Beta to Omicron variant‐driven waves	4
A novel reagent for the screening of Immunoglobulin A ‐deficient blood donors	4
Platelets retain function and can be stored following disruption of human leucocyte antigens	4
The availability of plasma donors and plasma: A sociologist's perspective	4
Association between NT‐proBNP and false‐positive Coombs test in patients with heart failure and elevated NT‐proBNP	4
Issue Information	4
Monitoring viral genomic sequences in transfusion‐transmitted viruses	4
The safety of pathogen‐reduced platelet transfusions in critically ill term and preterm neonates	4
A questionnaire‐based survey on conversion from whole blood to apheresis donations among group AB donors in Hong Kong	4
Autoantibodies to ADAMTS13 in human immunodeficiency virus‐associated thrombotic thrombocytopenic purpura	4
Factors influencing transfusion reactions in paediatric patients: Active haemovigilance data from a children's hospital in India	4
Transfusion efficacy of leucoreduced packed red blood cells prepared by two different methods: A randomized controlled trial in transfusion‐dependent thalassaemia patients (FUEL trial)	4
A retrospective analysis of postpartum red blood cell transfusions at a tertiary care obstetric centre	4
Challenges in promoting stewardship of albumin: A comparative perspective from recent guidelines	4
Issue Information	4
A scoping review of grey zone use for transfusion‐transmitted infection screening among blood donors	4

	4
The impact of non‐disclosure of HIV status and antiretroviral therapy on HIV recency testing and incidence algorithms	4
Clinical transfusion practice in Ethiopia	4
Development and validation of a scoring system to predict vasovagal reaction upon whole‐blood donation	4
Onsite vasovagal reactions with and without loss of consciousness are distinct outcomes with different risk factors	4
Impact of donor ferritin testing on iron deficiency prevention and blood availability in France: A cohort simulation study	4
Influence of donor age, sex and ethnicity on high‐titre anti‐A and ‐B: Review of 6 million donations from two national blood providers	4
Determination of CD177 (human neutrophil antigen 2) polymorphisms using nanopore sequencing	4
The importance of confirmatory assays in testing blood donors for human T‐cell lymphotropic virus	4
Donors in the COVID‐19 era: How did donor characteristics change in Japan?	4
	4
Transfusion‐related acute lung injury induced by human leucocyte antigen‐II antibodies: Analysis of antibody typing and source	4
Events	4
Issue Information	4
Incentives for plasma donation	4
Organizational monitoring of patient blood management implementation: Results of an Italian national survey	4
Prediction of blood volume to be processed to achieve a target number of CD34+ cells: Development, validation and implementation of a formula	4
A para‐Bombay phenotype due to compound heterozygosity involving a novel FUT1 variant	4
The effect of near‐infrared low‐level light on the in vitro quality of platelets during storage	4
Associated criteria used in investigating suspected septic transfusion reactions: A scoping review	4
The selection and preparation of red cell components for intrauterine transfusion: A national survey	4
Paediatric clinical decision support: Evaluation of a best practice alert for red blood cell transfusion	4
Blood collection technique and processing impact the nucleosomes and complement contents of platelet products	4
	3
Correction to ‘Potential benefits of an alternative haemoglobin deferral strategy evaluated in seven countries’	3
Protection of fundamental human rights by improving patient access to plasma‐derived therapies and donor health protection	3
Transfusion consent in Brazil: A nationwide survey of practices and form content	3
Blood bank preparedness for hurricanes and flooding: A Florida Blood Center's experiences and perspectives	3
Themed issue: Focusing on blood components	3
Optimization of the antibody identification interval in a high‐volume transfusion centre	3
Cryopreserved platelets washed with a dialysis machine for dimethyl sulphoxide removal	3
Contemporary patient blood management in abnormally invasive placenta at a tertiary centre, with a focus on the role of the transfusion practitioner	3
Extending the post‐thaw shelf‐life of cryoprecipitate when stored at refrigerated temperatures	3
Blood transfusion is associated with increased mortality for neonates with congenital diaphragmatic hernia on extracorporeal membrane oxygenation support	3
Validation of a flow‐cytometry‐based red blood cell antigen phenotyping method	3
Comparing the volume of umbilical cord blood collection using different techniques	3
Expansion strategies for umbilical cord blood haematopoietic stem cells in vitro	3
Using unmanned aerial vehicles (drones) to improve access to blood in low‐ and middle‐income countries: Current challenges and opportunities	3
Abstract	3
Response to comments from the International Patient Organization for Primary Immunodeficiencies on ‘Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low‐ and middle‐i	3
Events	3
An international survey on measures to prevent transfusion‐transmitted infectious diseases—study results 1: Participation rates and the presence of laws, regulations, standards and best practices	3
Is dual testing for hepatitis C necessary? Modelling the risk of removing hepatitis C antibody testing for Australian blood donations	3
The value of genetic data from 665,460 individuals in managing iron deficiency anaemia and suitability to donate blood	3
False‐positive infectious screening results among blood donors	3
‘Ironing out the risk’: Assessing the effect of plateletpheresis donation frequency on iron stores in South‐Asian male donors	3
Issue Information	3
Factors associated with aggregate formation in cold‐stored platelets	3
Split red blood cell units contain defined extracellular K + levels, which are improved by a washing procedure	3
Concerns regarding methodological and interpretive aspects in the evaluation of BTHC ‐ PAGGSM red	3
A congress report of the new Emerging Pathogens and Parasitology Subgroup within the ISBT Working Party on Transfusion‐Transmitted Infectious Disease	3
Impact of a rapid blood warmer on the quality and function of cold‐stored platelets	3
Vaccination and transfusion safety at the time of expanding use of live attenuated vaccines	3
Hepatitis E virus seropositivity in an ethnically diverse community blood donor population	3
Analysis of wrong blood in tube events at a hospital‐based blood centre in a tertiary care referral hospital: A perspective from a lower middle‐income country	3
Long‐term forecasting of blood donations using time series of donation activity: Findings from seven blood establishments	3
Three buffy coat platelet concentrates: Use of data modelling to make more with less	3
Explainable haemoglobin deferral predictions using machine learning models: Interpretation and consequences for the blood supply	3
Prevalence and diagnostic accuracy of syphilis screening in blood donors: A prospective observational study comparing three different serological platforms	3
Eye drops of human origin—Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies	3
Prevalence of adsorbed A antigen onto donor‐derived group O red cells in children following stem cell transplantation: A single‐centre evaluation	3
Paris Olympics and Paralympics: Insights from nationwide coordination in preparedness, supply chain management and blood inventory	3
HLA Class II regulation of immune response in sickle cell disease patients: Susceptibility to red blood cell alloimmunization (systematic review and meta‐analysis)	3
Cost‐effectiveness of cEK ‐preventive matched transfusion strategies for female transfusion recipients to prevent haemolytic disease of the foetus an	3
Prophylactic high‐dose granulocyte transfusions following allogeneic haematopoietic stem cell transplantation	3
International Forum on Management of Blood Donors with Culture‐Positive Platelet Donations: Responses	3
Trends in donor infection profiles and residual risks of transfusion‐transmitted human immunodeficiency virus, hepatitis C virus and hepatitis B virus after the implementation of universal mini‐pool n	3
Comparison of automated versus semi‐automated whole blood processing systems: A systematic review	3
A cross‐sectional study of haemolytic disease of the newborn in Uganda	3
Comment on ‘Comparing specificity and seroconversion sensitivity among major blood screening assays for human immunodeficiency virus and viral hepatitis’	3
Comment on McBride et al.'s ‘Can medical students use artificial intelligence to learn transfusion? Evaluating ChatGPT	3
Facilitators of and barriers to blood donation among voluntary non‐remunerated blood donors in sub‐Saharan Africa: A scoping review	3
From pH to glucose: Implementing a simple point‐of‐care method for platelet quality control	3
Issue Information	3
Routine maternal ABO/Rhesus D blood typing can alert of massive foetomaternal haemorrhage	3
Management of blood transfusion services in low‐resource countries	3
Raising the single‐unit transfusion benchmark in a national quality improvement campaign: Can we do better?	3
Detecting serologically difficult ABO blood groups using single‐molecule real‐time sequencing technology	3
Managing the risk of transfusion‐transmitted malaria from Australian blood donations: Recommendation of a new screening strategy	3
Issue Information	3
Bacterial screening of platelet components: Experience at a hospital‐based blood bank	3
Safeguarding plasma for fractionation: How can we deal with operational challenges in European Union countries	3
Significance of nucleic acid testing for transfusion safety in a country without deferral of men who have sex with men: Epidemiology of HIV among Pol	3
	3
Use of selective phenotyping and genotyping to identify rare blood donors in Canada	3
Using competition for plasma donor recruitment and retention: An Australian university case study	3
Issue Information	3
International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology Report of Basel and three virtual business meetings: Update on blood group systems	3
Effects of plasmapheresis frequency on health status and exercise performance in men: A randomized controlled trial	3
Simulated effects of ferritin screening on C‐reactive protein levels in recruited blood donors	3
An innovative modelling proposal for the blood supply chain	3
A comprehensive approach to continuous quality improvement of massive transfusion by developing key performance indicators	3
Prevalence of red blood cell alloantibodies among blood donors in the French Military Blood Institute: A 10‐year retrospective study	3
Can reactive donor screening results be presumed false positive following unstandardized testing procedures?	3
Evaluation of the in vitro quality of X‐ray irradiated red cell concentrates processed and stored using di(2‐ethylhexyl) terephthalate plasticized blood bag sets	3